Business Wire

Alkemics to Power productDNA:Hub – an Industry-Led Service to Help Retailers and Suppliers Share Product Data and Images

Del

A group of leading UK grocery retailers and suppliers facilitated by GS1 UK, the product data standards organisation, has selected Alkemics to power productDNA:hub, the new service that helps retailers and suppliers to share and manage product data and images.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180122005133/en/

The Alkemics platform that will power productDNA:hub (Photo: Alkemics)

The Alkemics platform that will power productDNA:hub (Photo: Alkemics)

Alkemics is a French software platform that facilitates product data sharing between brands and retailers, allowing them to collect and enrich their product data.

After a selection phase that included the testing of 25 international solution providers, Alkemics was chosen by the group of leading UK retailers and suppliers to power the collection, standardisation, and sharing of product data among manufacturers, brands, and retailers in the UK. Starting in the spring of 2018, several leading British retailers and brands will use the Alkemics platform to speed up the standardisation and sharing of product data in the grocery retail industry.

GS1 UK put out a call for bids in early 2017 on behalf of the industry group and two finalists were chosen after several phases of testing. The finalists, including Alkemics – whose platform is already used by 90% of the grocery e-retail market in France – then conducted a proof of concept test with three retailers – Tesco, Sainsbury’s, and Ocado – and four suppliers – Unilever, P&G, Nestlé, and Itsu.

John Martin, Head of productDNA at GS1 UK: “We completed a thorough, structured evaluation of leading product data management solutions against the needs of our community including pilots for a number of shortlisted vendors. We were fortunate to have massive support from retailers and manufacturers in this process, and the decision to select Alkemics was widely supported. The group, facilitated by GS1 UK, selected Alkemics to power productDNA:hub because of their deep understanding of the industry’s needs and their innovative, intuitive and flexible technology. They put us in an excellent position to deliver a single industry-wide solution to accelerate the grocery industry’s digital transformation. Their solution, which is designed and built for the cloud, manages commercial, supply chain, eCommerce and image data together. It was a perfect fit for productDNA:hub.”

High-quality, digitised and standardised product data is increasingly important to both suppliers and retailers. Logistical and regulatory data, marketing content, and visuals can now be used in a variety of different contexts – from retail information systems and databases, to logistics management and e-commerce sites. The growing need for transparency among consumers and the increasing number of distribution channels have also helped make product data a key concern for the retail industry.

To tackle the problem, twelve manufacturers and retailers, representing 80% of the UK grocery retail sector, worked with GS1 UK to find a single industry solution for product data management.

Gary Lynch, CEO of GS1 UK said: “Product data management and the sharing of information between suppliers and retailers has always been a challenge for the retail industry – our research suggests the industry could save £200m by improving data quality and facilitate data sharing. productDNA:hub is the solution to that problem.”

The Alkemics platform will offer a dashboard, data quality monitoring tools, and brand-retailer activity tracking. All data collected is also structured and standardised.

The single omni-channel platform addresses both the needs of offline and e-commerce business and its flexible data models, which can be modified “on the fly”, allowing the technology to adapt to growing needs of the retail industry in line with the evolution of GS1 UK standards.

“Nowadays, professionals from all departments, from IT to marketing to sales, have to access and use product data. Each of them needs to be able to easily add, view, and share data in a single secure location” explained Antoine Durieux, founder and CEO of Alkemics.

“We've developed a user-friendly, intuitive platform to meet the needs of a variety of different professionals, as effectively as possible. While more than 5500 brands have started using our platform over the past two years in France, this collaboration with GS1 UK is an important milestone in our development, as it not only shows our technology’s adaptability and scalability, but also our competitiveness alongside global industry leaders. Our software has proven to be a versatile and future-focused solution that will accompany the retail industry through its digital transformation. We are very pleased to have been selected by the industry group and GS1 UK as the technology provider to productDNA:hub.”

– Ends –

About Alkemics
Alkemics is the digital collaboration platform for retail. The cloud-based Saas solution helps retailers and brands digitize, collect and share product data in one single secured place. Alkemics facilitates collaboration and drive operational excellence with automated collection, correction and sharing of high quality product data (GS1 standard). After raising 20 million euros in a Series B funding round in September 2016, Alkemics has seen great success within the retail market in France over the past two years, with more than 5,500 brands and 90% of the grocery e-retailers joining the platform. Alkemics has launched several new retail industries in 2017(beauty and cosmetics, health, Out of Home…).

About GS1 UK
GS1 UK is a community of over 33,000 members working in retail, foodservice, healthcare and more. GS1 UK is one of 112 independent, not-for-profit GS1 organisations operating across 150 countries worldwide. GS1 UK helps everyone involved in making, moving and trading goods, automate and standardise their supply chain processes using the common language of GS1 global standards.

www.gs1uk.org

Contact information

Alkemics
Agence Raoul
Florence Calba / Pierre Gatey
0660242861 / 0607338945
alkemics@agenceraoul.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha